Quick Answer
Nutex Health Inc. reported Cash and Equivalents of $185.57 million for fiscal year 2025.
Nutex Health Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $185.57M | +356.6% |
| 2024 | $40.64M | +84.7% |
| 2023 | $22.00M | -35.8% |
| 2022 | $34.26M | -5.2% |
| 2021 | $36.12M | +134014.2% |
| 2020 | $26.9K | -97.5% |
| 2019 | $1.07M | +793.3% |
| 2018 | $119.3K | +1162.2% |
| 2017 | $9.4K | -10.2% |
| 2016 | $10.5K | -91.4% |
| 2015 | $122.3K | -3.6% |
| 2014 | $126.8K | +372.0% |
| 2013 | $26.9K | -74.3% |
| 2012 | $104.7K | -53.4% |
| 2011 | $224.8K | -51.7% |
| 2010 | $465.5K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $166.05M | +254.0% | +71.7% |
| June 30, 2025 | $96.73M | +137.0% | +10.3% |
| March 31, 2025 | $87.67M | +192.2% | +115.7% |
| December 31, 2024 | $40.64M | +84.7% | -13.4% |
| September 30, 2024 | $46.91M | +74.9% | +15.0% |
| June 30, 2024 | $40.81M | +24.6% | +36.0% |
| March 31, 2024 | $30.01M | -8.6% | +36.4% |
| December 31, 2023 | $22.00M | -35.8% | -18.0% |
- Nutex Health Inc. showed an increase of +356.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, Nutex Health Inc.’s cash and equivalents has grown by 39761.3% (from $465.5 thousand to $185.57 million).
- The most recent figure is from Nutex Health Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: